Home/Filings/4/0001437749-20-019524
4//SEC Filing

Schaffer Paul W. 4

Accession 0001437749-20-019524

CIK 0001029125other

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 9:28 PM ET

Size

6.8 KB

Accession

0001437749-20-019524

Insider Transaction Report

Form 4
Period: 2020-09-04
Transactions
  • Purchase

    Common Stock

    2020-09-04$2.51/sh+24,775$62,158159,195 total
  • Purchase

    Common Stock

    2020-09-08$2.55/sh+225$574159,420 total
Holdings
  • Common Stock

    (indirect: By Trust)
    30,665
Footnotes (1)
  • [F1]Reflects the weighted average price of 24,775 shares of common stock of Sun BioPharma, Inc. purchased by the reporting person in multiple transactions on September 4, 2020 with purchase prices ranging from $2.4298 to $2.55 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Issuer

Sun BioPharma, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001652797

Filing Metadata

Form type
4
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 9:28 PM ET
Size
6.8 KB